Researchers manipulate stem cells to grow virtually any cell type or organ in the laboratory. Ultimately, these cells could repair diseased and dysfunctional organs, phasing out organ transplants. While stem cell therapies have entered the clinic, several of them have been unsuccessful because they failed to repair diseased tissue or the recipient’s body rejected the cells. In this webinar, Michael Rudnicki and Evan Snyder will discuss the factors that determine stem cell therapy success.
Topics to be covered
Mobilizing muscle stem cells for therapy
How a novel class of signal-modifying drugs guide stem cells to their target location
Speakers
Michael Rudnicki, PhD Senior Scientist and Director, Regenerative Medicine Program Ottawa Hospital Research Institute
Evan Y. Snyder, MD, PhD Professor, Human Genetics Program Director, Center for Stem Cells and Regenerative Medicine Sanford Burnham Prebys Medical Discovery Institute
